DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1470-7330
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center ; volume:17 ; number:1 ; day:6 ; month:2 ; year:2017 ; pages:1-9 ; date:12.2017
Cancer imaging ; 17, Heft 1 (6.2.2017), 1-9, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Luz, Jose Hugo Mendes
- Contributor
-
Luz, Paula M.
Martin, Henrique S.
Gouveia, Hugo R.
Levigard, Raphal Braz
Nogueira, Felipe Diniz
Rodrigues, Bernardo Caetano
de Miranda, Tiago Nepomuceno
Mamede, Marcelo Henrique
SpringerLink (Online service)
- DOI
-
10.1186/s40644-017-0108-6
- URN
-
urn:nbn:de:1111-201703028910
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luz, Jose Hugo Mendes
- Luz, Paula M.
- Martin, Henrique S.
- Gouveia, Hugo R.
- Levigard, Raphal Braz
- Nogueira, Felipe Diniz
- Rodrigues, Bernardo Caetano
- de Miranda, Tiago Nepomuceno
- Mamede, Marcelo Henrique
- SpringerLink (Online service)
Other Objects (12)
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Complications after TACE in HCC – Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom
Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose
Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
Machine learning zur Verbesserung der Vorhersagequalität nach TACE bei HCC-Patienten
CXCL1 and CXCL6 are potential predictors for HCC response to TACE
Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?
A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Complications after TACE in HCC – Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom
Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose
Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
Machine learning zur Verbesserung der Vorhersagequalität nach TACE bei HCC-Patienten
CXCL1 and CXCL6 are potential predictors for HCC response to TACE
Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?
A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Complications after TACE in HCC – Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom
Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose
Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
Machine learning zur Verbesserung der Vorhersagequalität nach TACE bei HCC-Patienten
CXCL1 and CXCL6 are potential predictors for HCC response to TACE
Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?